This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $9,284.40 contract is for the supply of XOLAIR 150 MG/ML SYRINGE/ML, a specialty pharmaceutical product.
DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) under various prime vendor contracts. This specific delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue firm fixed-price orders for a comprehensive array of pharmaceutical items to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group's status as a woman-owned small business enables it to secure direct awards for these critical pharmaceutical supply programs without the use of set-asides.
Generated 10/23/24, 9:22 AM